Serina Therapeutics grants options to new employees to purchase shares of common stock.

From GlobeNewswire.: 2025-05-14 15:15:00

Serina Therapeutics, Inc. announced grants of options to purchase 15,000 shares of common stock to new non-executive employees as inducement for employment. These options will vest over three years, subject to continued employment. Serina is a biotechnology company developing drug candidates to treat neurological diseases using their proprietary POZ Platform™. For more information, visit https://serinatherapeutics.com. This release contains forward-looking statements and risks, as discussed in Serina’s Annual Report on Form 10-K for 2024 and periodic reports filed with the SEC. Contact [email protected] for inquiries.



Read more at GlobeNewswire.: Serina Therapeutics Makes Grants to New Employees Under